Baltimore-based Cerecor announces deal with Merck

Cerecor Inc., of Baltimore, a development-stage biotechnology company, said it has agreed to acquire potential treatments for Parkinson's disease and other central nervous system disorders from Merck & Co.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


Scroll To Top